BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22448262)

  • 21. D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.
    Choi S; Lew KL; Xiao H; Herman-Antosiewicz A; Xiao D; Brown CK; Singh SV
    Carcinogenesis; 2007 Jan; 28(1):151-62. PubMed ID: 16920735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.
    Yu CH; Kan SF; Pu HF; Jea Chien E; Wang PS
    Cancer Sci; 2008 Dec; 99(12):2467-76. PubMed ID: 19037992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells.
    Patra N; De U; Kang JA; Kim JM; Ahn MY; Lee J; Jung JH; Chung HY; Moon HR; Kim HS
    Eur J Pharmacol; 2011 May; 658(2-3):98-107. PubMed ID: 21376033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-methoxyestradiol blocks cell-cycle progression at G(2)/M phase and inhibits growth of human prostate cancer cells.
    Kumar AP; Garcia GE; Slaga TJ
    Mol Carcinog; 2001 Jul; 31(3):111-24. PubMed ID: 11479920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional p53 determines docetaxel sensitivity in prostate cancer cells.
    Liu C; Zhu Y; Lou W; Nadiminty N; Chen X; Zhou Q; Shi XB; deVere White RW; Gao AC
    Prostate; 2013 Mar; 73(4):418-27. PubMed ID: 22996738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
    Qiu J; Gao Z; Shima H
    Oncol Rep; 2012 Jan; 27(1):160-7. PubMed ID: 21947091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells.
    Ringer L; Sirajuddin P; Tricoli L; Waye S; Choudhry MU; Parasido E; Sivakumar A; Heckler M; Naeem A; Abdelgawad I; Liu X; Feldman AS; Lee RJ; Wu CL; Yenugonda V; Kallakury B; Dritschilo A; Lynch J; Schlegel R; Rodriguez O; Pestell RG; Avantaggiati ML; Albanese C
    Oncotarget; 2014 Nov; 5(21):10678-91. PubMed ID: 25296977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells.
    Devlin HL; Mack PC; Burich RA; Gumerlock PH; Kung HJ; Mudryj M; deVere White RW
    Mol Cancer Res; 2008 May; 6(5):808-18. PubMed ID: 18505925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
    Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
    J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2.
    Shetty A; Dasari S; Banerjee S; Gheewala T; Zheng G; Chen A; Kajdacsy-Balla A; Bosland MC; Munirathinam G
    Urol Oncol; 2016 Nov; 34(11):483.e1-483.e8. PubMed ID: 27692835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.
    Kiviharju TM; Lecane PS; Sellers RG; Peehl DM
    Clin Cancer Res; 2002 Aug; 8(8):2666-74. PubMed ID: 12171899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cadmium-induced malignant transformation of human prostate epithelial cells.
    Achanzar WE; Diwan BA; Liu J; Quader ST; Webber MM; Waalkes MP
    Cancer Res; 2001 Jan; 61(2):455-8. PubMed ID: 11212230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.
    Mimeault M; Venkatraman G; Johansson SL; Moore E; Henichart JP; Depreux P; Lin MF; Batra SK
    Int J Cancer; 2007 Jan; 120(1):160-9. PubMed ID: 17013895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergence to apoptosis from ROS induced cell cycle arrest: effect of cadmium.
    Chatterjee S; Kundu S; Sengupta S; Bhattacharyya A
    Mutat Res; 2009 Apr; 663(1-2):22-31. PubMed ID: 19475715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Combination of Metformin and Valproic Acid Induces Synergistic Apoptosis in the Presence of p53 and Androgen Signaling in Prostate Cancer.
    Tran LNK; Kichenadasse G; Butler LM; Centenera MM; Morel KL; Ormsby RJ; Michael MZ; Lower KM; Sykes PJ
    Mol Cancer Ther; 2017 Dec; 16(12):2689-2700. PubMed ID: 28802253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis.
    Achanzar WE; Achanzar KB; Lewis JG; Webber MM; Waalkes MP
    Toxicol Appl Pharmacol; 2000 May; 164(3):291-300. PubMed ID: 10799339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo.
    Zhou R; Lu Z; Liu K; Guo J; Liu J; Zhou Y; Yang J; Mi M; Xu H
    Curr Cancer Drug Targets; 2015; 14(9):860-71. PubMed ID: 25431082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
    Tang DG; Li L; Chopra DP; Porter AT
    Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms.
    Gupta K; Thakur VS; Bhaskaran N; Nawab A; Babcook MA; Jackson MW; Gupta S
    PLoS One; 2012; 7(12):e52572. PubMed ID: 23285096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin.
    Zhang Y; Dong Y; Melkus MW; Yin S; Tang SN; Jiang P; Pramanik K; Wu W; Kim S; Ye M; Hu H; Lu J; Jiang C
    Mol Cancer Ther; 2018 Nov; 17(11):2341-2352. PubMed ID: 30166403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.